Belmont, MA, United States of America

Daniel I Kagan

USPTO Granted Patents = 7 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2002-2021

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Daniel I Kagan

Introduction

Daniel I Kagan is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of nutraceuticals, holding a total of 7 patents. His work focuses on improving the bioavailability of various compounds, which has important implications for health and wellness.

Latest Patents

One of his latest patents is titled "Nutraceuticals having sustained release for improved bioavailability and method of production." This patent describes economical processes to enhance the bioavailability of nutraceuticals through formulations that induce micronization and sustained release. The inventive process aims to increase the solubility and bioavailability of lipophilic and moderately water-soluble nutraceuticals by combining excipients that enhance solubility and promote sustained release of active compounds. Additionally, it addresses the need to increase the residence time of highly water-soluble nutraceuticals that are quickly metabolized and eliminated from the body, thereby enhancing their therapeutic potential. The formulations are designed to be freely flowing powders, suitable for incorporation into tablets, capsules, or used as bulk powders.

Another significant patent is "Water dispersible policosanol cyclodextrin complex and method of its production." This patent discloses a formulation of policosanol with natural cyclodextrins, resulting in a water-dispersible form of policosanol. The process provides an economical commercial method for creating the policosanol complex, which is suitable for oral dosage forms and functional foods. The method includes preparing a policosanol cyclodextrin complex and administering it to an animal, with a preference for human ingestion. The complex can be formulated into various forms, including hard gelatin capsules, tablets, or wafers, and may contain both active and inactive ingredients.

Career Highlights

Daniel I Kagan is currently associated with Bioactives LLC, where he continues to innovate in the field of nutraceuticals. His work has been instrumental in developing new formulations that enhance the effectiveness of health supplements.

Collaborations

He collaborates with Doddabele L Madhavi, contributing to the advancement of their shared goals in the nutraceutical industry.

Conclusion

Daniel I Kagan's innovative work in nutraceuticals demonstrates his commitment to improving health outcomes through scientific advancements. His patents reflect a deep understanding of formulation science and its applications in enhancing bio

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…